Recurrent tuberculosis and its risk factors: Adequately treated patients are still at high risk

G. W. Comstock, Jonathan E Golub, Rajesh Panjabi

Research output: Contribution to journalArticle

Abstract

Recurrent tuberculosis (TB) poses significant threats, including drug resistance, to TB control programs. However, recurrence and its causes, particularly in the era of epidemic human immunodeficiency virus (HIV), have not been well described. We systematically searched published material for studies reporting on recurrent TB following completion of standard treatment regimens to provide data on the issue. A total of 32 studies were reviewed. Among controlled trials, the overall recurrence rates (per 100 000 person-years) were respectively 3010 (95%CI 2230-3970) and 2290 (95%CI 1730-2940) at 6 and 12 months after treatment completion. Recurrence rates were higher among observational studies compared to controlled trials and in countries with high versus low background TB incidence. TB recurrence (%) was higher among HIV-infected (6.7, 95%CI 5.9-7.6) than non-HIV-infected individuals (3.3, 95%CI 2.8-3.9). Factors independently associated with recurrence in the literature included residual cavitation, greater area of involved lung tissue, positive sputum culture at 2 months of treatment and HIV infection. Among those with HIV infection, recurrent TB was associated with a low initial CD4 count and receiving less than 37 weeks of antituberculosis treatment. We argue that adequately treated patients are still at high risk for recurrent disease and should be considered in case-finding strategies. Moreover, those with multiple risk factors may benefit from modification of standard treatment.

Original languageEnglish (US)
Pages (from-to)828-837
Number of pages10
JournalInternational Journal of Tuberculosis and Lung Disease
Volume11
Issue number8
StatePublished - Aug 2007

Fingerprint

Tuberculosis
Recurrence
HIV
Virus Diseases
Therapeutics
CD4 Lymphocyte Count
Sputum
Drug Resistance
Observational Studies
Viruses
Lung
Incidence

Keywords

  • Pulmonary tuberculosis
  • Recurrence
  • Risk factors

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Recurrent tuberculosis and its risk factors : Adequately treated patients are still at high risk. / Comstock, G. W.; Golub, Jonathan E; Panjabi, Rajesh.

In: International Journal of Tuberculosis and Lung Disease, Vol. 11, No. 8, 08.2007, p. 828-837.

Research output: Contribution to journalArticle

@article{c294c085b34d406ea95c36079520c039,
title = "Recurrent tuberculosis and its risk factors: Adequately treated patients are still at high risk",
abstract = "Recurrent tuberculosis (TB) poses significant threats, including drug resistance, to TB control programs. However, recurrence and its causes, particularly in the era of epidemic human immunodeficiency virus (HIV), have not been well described. We systematically searched published material for studies reporting on recurrent TB following completion of standard treatment regimens to provide data on the issue. A total of 32 studies were reviewed. Among controlled trials, the overall recurrence rates (per 100 000 person-years) were respectively 3010 (95{\%}CI 2230-3970) and 2290 (95{\%}CI 1730-2940) at 6 and 12 months after treatment completion. Recurrence rates were higher among observational studies compared to controlled trials and in countries with high versus low background TB incidence. TB recurrence ({\%}) was higher among HIV-infected (6.7, 95{\%}CI 5.9-7.6) than non-HIV-infected individuals (3.3, 95{\%}CI 2.8-3.9). Factors independently associated with recurrence in the literature included residual cavitation, greater area of involved lung tissue, positive sputum culture at 2 months of treatment and HIV infection. Among those with HIV infection, recurrent TB was associated with a low initial CD4 count and receiving less than 37 weeks of antituberculosis treatment. We argue that adequately treated patients are still at high risk for recurrent disease and should be considered in case-finding strategies. Moreover, those with multiple risk factors may benefit from modification of standard treatment.",
keywords = "Pulmonary tuberculosis, Recurrence, Risk factors",
author = "Comstock, {G. W.} and Golub, {Jonathan E} and Rajesh Panjabi",
year = "2007",
month = "8",
language = "English (US)",
volume = "11",
pages = "828--837",
journal = "International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "International Union against Tubercul. and Lung Dis.",
number = "8",

}

TY - JOUR

T1 - Recurrent tuberculosis and its risk factors

T2 - Adequately treated patients are still at high risk

AU - Comstock, G. W.

AU - Golub, Jonathan E

AU - Panjabi, Rajesh

PY - 2007/8

Y1 - 2007/8

N2 - Recurrent tuberculosis (TB) poses significant threats, including drug resistance, to TB control programs. However, recurrence and its causes, particularly in the era of epidemic human immunodeficiency virus (HIV), have not been well described. We systematically searched published material for studies reporting on recurrent TB following completion of standard treatment regimens to provide data on the issue. A total of 32 studies were reviewed. Among controlled trials, the overall recurrence rates (per 100 000 person-years) were respectively 3010 (95%CI 2230-3970) and 2290 (95%CI 1730-2940) at 6 and 12 months after treatment completion. Recurrence rates were higher among observational studies compared to controlled trials and in countries with high versus low background TB incidence. TB recurrence (%) was higher among HIV-infected (6.7, 95%CI 5.9-7.6) than non-HIV-infected individuals (3.3, 95%CI 2.8-3.9). Factors independently associated with recurrence in the literature included residual cavitation, greater area of involved lung tissue, positive sputum culture at 2 months of treatment and HIV infection. Among those with HIV infection, recurrent TB was associated with a low initial CD4 count and receiving less than 37 weeks of antituberculosis treatment. We argue that adequately treated patients are still at high risk for recurrent disease and should be considered in case-finding strategies. Moreover, those with multiple risk factors may benefit from modification of standard treatment.

AB - Recurrent tuberculosis (TB) poses significant threats, including drug resistance, to TB control programs. However, recurrence and its causes, particularly in the era of epidemic human immunodeficiency virus (HIV), have not been well described. We systematically searched published material for studies reporting on recurrent TB following completion of standard treatment regimens to provide data on the issue. A total of 32 studies were reviewed. Among controlled trials, the overall recurrence rates (per 100 000 person-years) were respectively 3010 (95%CI 2230-3970) and 2290 (95%CI 1730-2940) at 6 and 12 months after treatment completion. Recurrence rates were higher among observational studies compared to controlled trials and in countries with high versus low background TB incidence. TB recurrence (%) was higher among HIV-infected (6.7, 95%CI 5.9-7.6) than non-HIV-infected individuals (3.3, 95%CI 2.8-3.9). Factors independently associated with recurrence in the literature included residual cavitation, greater area of involved lung tissue, positive sputum culture at 2 months of treatment and HIV infection. Among those with HIV infection, recurrent TB was associated with a low initial CD4 count and receiving less than 37 weeks of antituberculosis treatment. We argue that adequately treated patients are still at high risk for recurrent disease and should be considered in case-finding strategies. Moreover, those with multiple risk factors may benefit from modification of standard treatment.

KW - Pulmonary tuberculosis

KW - Recurrence

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=34547751289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547751289&partnerID=8YFLogxK

M3 - Article

C2 - 17705947

AN - SCOPUS:34547751289

VL - 11

SP - 828

EP - 837

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

SN - 1027-3719

IS - 8

ER -